Knowledge, Attitudes and Practices of Flu Vaccination in Hemodialysis Patients
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Neovius, M.; Jacobson, S.H.; Eriksson, J.K.; Elinder, C.G.; Hylander, B. Mortality in chronic kidney disease and renal replacement therapy: A population-based cohort study. BMJ Open 2014, 4, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Ortiz, A.; Covic, A.; Fliser, D.; Fouque, D.; Goldsmith, D.; Kanbay, M.; Mallamaci, F.; Massy, Z.A.; Rossignol, P.; Vanholder, R.; et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 2014, 383, 1831–1843. [Google Scholar] [CrossRef]
- Pesanti, E.L. Immunologic defects and vaccination in patients with chronic renal failure. Infect. Dis. Clin. N. Am. 2001, 15, 813–832. [Google Scholar] [CrossRef]
- Grzegorzewska, A.E. Prophylactic vaccinations in chronic kidney disease. Hum. Vaccines Immunother. 2015, 11, 2599–2605. [Google Scholar] [CrossRef]
- Kato, S.; Chmielewski, M.; Honda, H.; Pecoits-Filho, R.; Matsuo, S.; Yuzawa, Y.; Tranaeus, A.; Stenvinkel, P.; Lindholm, B. Aspects of immune dysfunction in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 2008, 3, 1526–1533. [Google Scholar] [CrossRef]
- Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. Suppl. 2013, 3, 1–150. [Google Scholar]
- Grzegorzewska, A.E. Hepatitis B vaccination in chronic kidney disease: Review of evidence in non-dialyzed patients. Hepat. Mon. 2012, 12, e7359. [Google Scholar] [CrossRef]
- Grzegorzewska, A.E. Hepatitis B vaccination in chronic kidney disease patients: A call for novel vaccines. Expert Rev. Vaccines 2014, 13, 1317–1326. [Google Scholar] [CrossRef]
- Mathew, R.; Mason, D.; Kennedy, J.S. Vaccination issues in patients with chronic kidney disease. Expert Rev. Vaccines 2014, 13, 285–298. [Google Scholar] [CrossRef]
- Durlik, M.; Ciancira, J.; Rutkowski, B. Zalecenia postępowania profilaktycznego i leczniczego w zakażeniach wirusami zapalenia wątroby typu B i C u pacjentów z przewlekłymi chorobami nerek. Nefrologia Dializoterapia Polska 2007, 11, 141–145. [Google Scholar]
- Sarnak, M.J.; Jaber, B.L. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001, 120, 1883–1887. [Google Scholar] [CrossRef] [PubMed]
- Sarnak, M.J.; Jaber, B.L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000, 58, 1758–1764. [Google Scholar] [CrossRef] [PubMed]
- Dalrymple, L.S.; Go, A.S. Epidemiology of Acute Infections among Patients with Chronic Kidney Disease. Clin. J. Am. Soc. Nephrol. 2008, 3, 1487–1493. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 1997, 46, 1–24. [Google Scholar]
- Fiore, A.E.; Shay, D.K.; Haber, P.; Iskander, J.K.; Uyeki, T.M.; Mootrey, G.; Bresee, J.S.; Cox, N.J. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2007, 56, 1–54. [Google Scholar]
- Naqvi, S.B.; Collins, A.J. Infectious Complications in Chronic Kidney Disease. Adv. Chronic Kidney Dis. 2006, 13, 199–204. [Google Scholar] [CrossRef]
- DaRoza, G.; Loewen, A.; Djurdjev, O.; Love, J.; Kempston, C.; Burnett, S.; Kiaii, M.; Taylor, P.A.; Levin, A. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better. Am. J. Kidney Dis. 2003, 42, 1184–1192. [Google Scholar] [CrossRef]
- Gilbertson, D.T.; Unruh, M.; McBean, A.M.; Kausz, A.T.; Snyder, J.J.; Collins, A.J. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int. 2003, 63, 738–743. [Google Scholar] [CrossRef]
- Wang, I.K.; Lin, C.L.; Lin, P.C.; Liang, C.C.; Liu, Y.L.; Chang, C.T.; Yen, T.H.; Morisky, D.E.; Huang, C.C.; Sung, F.C. Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: A population-based study. Vaccine 2012, 31, 718–724. [Google Scholar] [CrossRef]
- Bond, T.C.; Spaulding, A.C.; Krisher, J.; McClellan, W. Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am. J. Kidney Dis. 2012, 60, 959–965. [Google Scholar] [CrossRef]
- Bertoldo, G.; Annalisa, Pesce, A.; Pepe, A.; Concetta Paola Pelullo, C.P.; Di Giuseppe, G.D. Seasonal influenza: Knowledge, attitude and vaccine uptake among adults with chronicconditions in Italy. PLoS ONE 2019, 14, e0215978. [Google Scholar] [CrossRef]
- Luz, P.M.; Johnson, R.E.; Brown, H.E. Workplace availability, risk group and perceived barriers predictive of 2016–17 influenza vaccine uptake in the United States: A cross-sectional study. Vaccine 2017, 35, 5890–5896. [Google Scholar] [CrossRef] [PubMed]
- Casalino, E.; Ghazali, A.; Bouzid, D.; Antoniol, S.; Pereira, L.; Kenway, P.; Choquet, C. Patient’s behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient’s influenza vaccine uptake. PLoS ONE 2018, 13, e0193029. [Google Scholar] [CrossRef]
- Jorgensen, P.; Mereckiene, J.; Cotter, S.; Johansen, K.; Tsolova, S.; Brown, C. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine 2018, 36, 442–452. [Google Scholar] [CrossRef] [PubMed]
- Giese, C.; Mereckiene, J.; Danis, K.; O’Donnell, J.; O’Flanagan, D.; Cotter, S. Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination. Vaccine 2016, 34, 3657–3662. [Google Scholar] [CrossRef] [PubMed]
- Bodeker, B.; Remschmidt, C.; Schmich, P.; Wichmann, O. Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health 2015, 15, 618. [Google Scholar] [CrossRef]
- Garthwaite, E.; Reddy, V.; Douthwaite, S.; Lines, S.; Tyerman, K.; Eccles, J. Clinical practice guideline management of blood borne viruses within the haemodialysis unit. BMC Nephrol. 2019, 20, 388. [Google Scholar] [CrossRef]
- Kliś, A. Vaccinations in patients with chronic disease disease. Nephrol. Forum 2019, 12, 133–139. [Google Scholar]
- Malhi, G.; Rumman, A.; Thanabalan, R.; Croitoru, K.; Silverberg, M.S.; Steinhart, H.A.; Nguyen, G.C. Vaccination in Inflammatory Bowel Disease Patients: Attitudes, Knowledge, and Uptake. J. Crohn’s Colitis 2015, 9, 439–444. [Google Scholar] [CrossRef]
- Nitsch-Osuch, A.; Gołębiak, I.; Wyszkowska, D.; Rosińska, R.; Kargul, L.; Szuba, B.; Brydak, L.B. Influenza Vaccination Coverage Among Polish Patients with Chronic Diseases. Adv. Exp. Med. Biol. 2017, 10, 968. [Google Scholar]
- Bohlke, K.; Davis, R.L.; Marcy, S.M.; Braun, M.M.; DeStefano, F.; Black, S.B.; Mullooly, J.P.; Thompson, R.S. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003, 112, 815–820. [Google Scholar] [CrossRef] [PubMed]
- Hui-Chen, L.; Hui-Fen, C.; Shu-Chen, H.; Chun-Yuh, Y. Association of Influenza Vaccination and Reduced Risk of Stroke Hospitalization among the Elderly: A Population-Based Case-Control. Int. J. Environ. Res. Public Health 2014, 11, 3639–3649. [Google Scholar]
- Lindsberg, P.; Grau, A.J. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34, 2518–2532. [Google Scholar] [CrossRef] [PubMed]
- Grau, A.J.; Fischer, B.; Barth, C.; Ling, P.; Lichy, C.; Buggle, F. Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005, 36, 1501–1506. [Google Scholar] [CrossRef]
- Lee, K.R.; Bae, J.H.; Hwang, I.C.; Kim, K.K.; Suh, H.S.; Ko, K.D. Effect of Influenza Vaccination on Riskof Stroke: A Systematic Review and Meta-Analysis. Neuroepidemiology 2017, 48, 103–110. [Google Scholar] [CrossRef]
- Siriwardena, A.N.; Gwini, S.M.; Coupland, C.A.C. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: Matched case–control study. Can. Med. Assoc. J. 2010, 15, 182. [Google Scholar] [CrossRef]
- Olatunbosuna, O.D.; Esterhuizenb, T.M.; Wiysongec, C.S. A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa. Vaccine 2017, 35, 6375–6386. [Google Scholar] [CrossRef]
- Tan, E.K.; Lim, L.H.; Teoh, Y.L.; Ong, G.; Bock, H.L. Influenza and seasonal influenza vaccination among diabetics in Singapore: Knowledge, attitudes and practices. Singapore Med. J. 2010, 51, 623–630. [Google Scholar]
- Ogólnopolski Program Zwalczania Grypy—National Program for Combating Influenza. Available online: http://opzg.pl (accessed on 18 November 2020).
- Dower, J.; Donald, M.; Begum, N.; Vlack, S.; Ozolins, I. Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia. Vaccine 2011, 29, 3031–3037. [Google Scholar] [CrossRef]
Variables | CDC (No = 103) | SDC (No = 90) | p |
---|---|---|---|
Age y. ± SD | 64.48 ± 14.64 | 62.54 ± 14.11 | 0.354 |
Female (1) No (%) | 53 (51) | 37 (41) | 0.385 * |
Basic education (1) No (%) | 30 (29) | 30 (33) | 0.648 * |
High school education (1) No (%) | 51 (50) | 53 (59) | 0.476 * |
Higher education (1) No (%) | 22 (21) | 9 (10) | 0.067 * |
Weight kg ± SD | 75.41 ± 18.11 | 80.27 ± 16.87 | 0.059 |
BMI kg/m² ± SD | 27.42 ± 5.78 | 28.37 ± 6.19 | 0.271 |
Diabetes (1) No (%) | 30 (29) | 37 (41) | 0.226 * |
Combined comorbidity (1) No (%) | 32 (31) | 46 (51) | 0.066 * |
Variables | Patients Regularly Vaccinated against Influenza—One a Year (No = 87) | Patients Irregularly or Not Vaccinated against Influenza (No = 106) | p |
---|---|---|---|
Age y. ± SD | 64.09 ± 14.06 | 62.94 ± 14.83 | 0.601 |
Female No (%) | 31 (30.1) | 59 (55.7) | 0.09 * |
Basic education No (%) | 32(36.8) | 28(26.4) | 0.31 * |
High school education No (%) | 46 (52.9) | 58 (54.7) | 0.89 * |
Higher education No (%) | 9 (10.3) | 20 (18.9) | 0.15 * |
Weight kg ± SD | 75.03 ± 18.88 | 82.66 ± 21.03 | 0.291 |
Diabetes No (%) | 32 (36.8) | 35 (33) | 0.70 * |
Combined comorbidity No (%) | 45 (51.7) | 34 (32) | 0.08 * |
HD vintage m ± SD | 57.96 ± 53.50 | 49.72 ± 56.85 | 0.550 |
Patients from SDC No (%) | 67 (77) | 23 (21.7) | <0.01 * |
Vaccination concerns and obstacles | |||
Patient did not know that they should be vaccinated against influenza No (%) | 0 (0) | 24 (22.6) | <0.01 * |
Patient was afraid of vaccine side effects No (%) | 0 (0) | 31 (29.2) | <0.01 * |
Patient thinks that vaccination takes too much time No (%) | 0 (0) | 4 (3.8) | 0.07 * |
Patient thinks that the vaccine is too expensive No (%) | 0 (0) | 6 (5.7) | <0.05 * |
Patient thinks that influenza vaccinations are ineffective No (%) | 1 (1.1) | 28 (26.4) | <0.01 * |
Patients with any concerns and obstacles No (%) | 1 (1.1) | 96 (90.6) | <0.01 * |
Who or what is a reliable source of information for patient about vaccinations? | |||
Nephrologist No (%) | 72 (82.8) | 74 (70) | 0.44 * |
Family doctor No (%) | 36 (41.4) | 60 (56.6) | 0.22 * |
Medical press No (%) | 2 (2.2) | 14 (13.2) | <0.05 * |
Daily or popular press No (%) | 0 (0) | 6 (5.7) | <0.05 * |
Family or friends No (%) | 2 (2.2) | 6 (5.7) | 0.26 * |
Vaccination websites No (%) | 0 (0) | 6 (5.7) | <0.05 * |
Patients who believe vaccination is effective No (%) | 76 (87.4) | 33 (31.1) | <0.01 * |
Patients vaccinated in the past No (%) | 65 (74.7) | 30 (28.3) | <0.01 * |
Variables | OR | 95% CI | p | Estimate |
---|---|---|---|---|
Age (y.) | 0.994 | 0.975–1.014 | 0.579 | −0.006 |
Female (1) | 0.441 | 0.246–0.790 | 0.006 | −0.819 |
Basic education (1) | 1.621 | 0.878–2.993 | 0.123 | 0.483 |
High school education (1) | 0.929 | 0.526–1.640 | 0.798 | −0.074 |
Higher education (1) | 0.496 | 0.213–1.154 | 0.104 | −0.701 |
Weight (kg) | 1.024 | 1.008–1.040 | 0.004 | 0.023 |
Diabetes (1) | 1.180 | 0.651–2.139 | 0.585 | 0.166 |
Combined comorbidity (1) | 2.269 | 1.263–4.076 | 0.006 | 0.819 |
HD vintage (m) | 0.997 | 0.992–1.003 | 0.304 | −0.003 |
Vaccination concerns and obstacles | ||||
Patient did not know that they should be vaccinated against influenza (1) | 0.000 | 0.000–0.244 | 0.997 | −20.262 |
Patient was afraid of vaccine side effects (1) | 0.000 | 0.000 | 0.996 | −20.351 |
Patient thinks that vaccination takes too much time (1) | 0.000 | 0.000 | 0.997 | −18.044 |
Patient thinks that the vaccine is too expensive (1) | 0.000 | 0.000 | 0.997 | −19.064 |
Patient thinks that influenza vaccinations are ineffective (1) | 0.032 | 0.004–0.244 | 0.001 | −3.430 |
Patients with any concerns and obstacles (1) | 0.001 | 0.000–0.010 | 0.000 | −6.716 |
Who or what is a reliable source of information for patient about vaccinations? | ||||
Nephrologist (1) | 2.076 | 1.037–4.154 | 0.0391 | 0.730 |
Family doctor (1) | 0.541 | 0.305–0.961 | 0.0361 | −0.614 |
Medical press (1) | 0.155 | 0.034 | 0.015 | −1.867 |
Daily or popular press (1) | 0.000 | 0.000 | 0.997 | −19.064 |
Family or friends (1) | 0.392 | 0.077–1.994 | 0.259 | −0.936 |
Vaccination websites (1) | 0.000 | 0.000 | 0.997 | −19.064 |
Patients who believe vaccination effective (1) | 15.284 | 7.189–32.492 | 0.000 | 2.727 |
Patients vaccinated in the past (1) | 7.485 | 3.938–14.225 | 0.000 | 2.013 |
Variables | adj. OR | 95% CI | p | Estimate | LR * (p) |
---|---|---|---|---|---|
Patients who believe vaccination are effective (1) | 9.863 | 4.357–22.326 | 0.000 | 2.289 | <0.01 |
Vaccinated in the past (1) | 5.179 | 2.367–11.332 | 0.000 | 1.645 | <0.01 |
Combined comorbidity (1) | 2.448 | 1.127–5.318 | 0.024 | 0.895 | <0.01 |
Female (1) | 0.408 | 0.189–0.882 | 0.023 | −0.896 | <0.05 |
Variables | Group A Vaccination Effective (No = 109) | Group B Vaccination Ineffective (No = 84) | p |
---|---|---|---|
Age y. ± SD | 63.1 ± 14.6 | 64.2 ± 14.2 | 0.61 |
Female No (%) | 45 (41.2) | 45 (53.5) | 0.308 * |
Basic education No (%) | 33 (30.5) | 27 (32.1) | 0.840 * |
High school education No (%) | 64 (58.7) | 40 (47.6) | 0.398 * |
Higher education No (%) | 12 (11) | 17 (20.3) | 0.127 * |
Weight kg ±SD | 80.1 ± 21 | 76.3 ± 18.9 | 0.19 |
Diabetes No (%) | 40 (36.7) | 25 (29.8) | 0.47 * |
Combined comorbidity No (%) | 79 (72) | 53 (63) | 0.55 * |
HD vintage m ± SD | 56.2 ± 61.2 | 51.7 ± 46.1 | 0.58 |
Patients from SDC No (%) | 69 (63.3) | 21 (25) | <0.01 * |
Vaccination concerns and obstacles | |||
Patient did not know that they should be vaccinated against influenza No (%) | 9 (8.3) | 15 (17.9) | 0.08 * |
Patient was afraid of vaccine side effects No (%) | 10 (9.2) | 21 (25) | <0.05 * |
Patient thinks that vaccination takes too much time No (%) | 1 (0.9) | 3 (3.6) | 0.21 * |
Patient thinks that the vaccine is too expensive No (%) | 2 (1.8) | 4 (4.8) | 0.26 * |
Patients with any concerns and obstacles No (%) | 29 (26.6) | 68 (8.9) | <0.01 * |
Who or what is a reliable source of information for patient about vaccinations? | |||
Nephrologist No (%) | 89 (81.7) | 57 (67.9) | 0.41 * |
Family doctor No (%) | 48 (44) | 48 (57.1) | 0.29 * |
Medical press No (%) | 7 (6.4) | 9 (10.7) | 0.32 * |
Daily or popular press No (%) | 2 (1.8) | 4 (4.8) | 0.26 * |
Family or friends No (%) | 2 (1.8) | 6 (7.1) | 0.08 * |
Vaccination websites No (%) | 1 (0.9) | 5 (6) | 0.053 * |
Patients regularly vaccinated against influenza—one a year No (%) | 76 (70) | 11 (13) | <0.01 * |
Patients vaccinated in the past No (%) | 74 (67.9) | 21 (25) | <0.01 * |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gawryś, A.; Gołębiowski, T.; Zielińska, D.; Augustyniak-Bartosik, H.; Kuriata-Kordek, M.; Szenborn, L.; Krajewska, M. Knowledge, Attitudes and Practices of Flu Vaccination in Hemodialysis Patients. Vaccines 2021, 9, 77. https://doi.org/10.3390/vaccines9020077
Gawryś A, Gołębiowski T, Zielińska D, Augustyniak-Bartosik H, Kuriata-Kordek M, Szenborn L, Krajewska M. Knowledge, Attitudes and Practices of Flu Vaccination in Hemodialysis Patients. Vaccines. 2021; 9(2):77. https://doi.org/10.3390/vaccines9020077
Chicago/Turabian StyleGawryś, Ada, Tomasz Gołębiowski, Dorota Zielińska, Hanna Augustyniak-Bartosik, Magdalena Kuriata-Kordek, Leszek Szenborn, and Magdalena Krajewska. 2021. "Knowledge, Attitudes and Practices of Flu Vaccination in Hemodialysis Patients" Vaccines 9, no. 2: 77. https://doi.org/10.3390/vaccines9020077
APA StyleGawryś, A., Gołębiowski, T., Zielińska, D., Augustyniak-Bartosik, H., Kuriata-Kordek, M., Szenborn, L., & Krajewska, M. (2021). Knowledge, Attitudes and Practices of Flu Vaccination in Hemodialysis Patients. Vaccines, 9(2), 77. https://doi.org/10.3390/vaccines9020077